Haohai Biological
Haohai Biological Engineering Co., Ltd., commonly referred to as Haohai Biological, is a leading player in the biotechnology industry, headquartered in China. Established in 1999, the company has made significant strides in the development and production of biological products, particularly in the fields of regenerative medicine and biopharmaceuticals. With a strong operational presence across various regions in China, Haohai Biological is renowned for its innovative core products, including advanced tissue engineering solutions and high-quality biological materials. These offerings are distinguished by their commitment to safety and efficacy, positioning the company as a trusted name in the market. Haohai Biological has achieved notable milestones, including successful collaborations and a robust portfolio of patents, solidifying its reputation as a pioneer in the biotechnology sector. As the company continues to expand its influence, it remains dedicated to advancing healthcare through cutting-edge biological solutions.
DitchCarbon Score
How does Haohai Biological's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Furniture Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Haohai Biological's score of 24 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Haohai Biological's reported carbon emissions
In 2023, Haohai Biological reported total carbon emissions of approximately 24,378,000 kg CO2e, comprising 4,689,000 kg CO2e from Scope 1 and 19,689,000 kg CO2e from Scope 2 emissions. The company has not disclosed any specific reduction targets or initiatives, nor does it appear to have made a climate pledge. In previous years, emissions have fluctuated, with total emissions recorded at about 22,293,000 kg CO2e in 2022, 25,860,000 kg CO2e in 2021, and 20,651,000 kg CO2e in 2020. The trend indicates a general increase in emissions over the years, with Scope 1 and Scope 2 emissions contributing significantly to the total. Haohai Biological's commitment to addressing climate change remains unclear, as there are no documented reduction targets or initiatives available. The company operates within a global context where many organisations are increasingly focusing on sustainability and carbon neutrality, highlighting the importance of establishing clear climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 2,876,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 15,162,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 00,000,000 | - | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Haohai Biological is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
